Protective Effect of Hydroxysafflor Yellow A on Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Rats

被引:0
|
作者
JIN Ming [1 ]
WANG Lin [1 ]
WU Yan [1 ]
ZANG Bao-xia [1 ]
TAN Li [1 ]
机构
[1] Department of Pharmacology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital,Capital Medical University
关键词
hydroxysafflor yellow A; pulmonary fibrosis; pulmonary inflammation; nuclear factor-κB p65; α-smooth muscle actin; Chinese medicine;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
1008 ;
摘要
Objective: To observe the effect of hydroxysafflor yellow A(HSYA), an active ingredient of a traditional Chinese herbal medicine Carthamus tinctorius L., on lung inflammation and pulmonary fibrosis induced by bleomycin(BLM) in rats. Methods: Animals were divided into 6 groups including normal group, model group, three HSYA groups and dexamethasone(DXM) group. Three doses of HSYA(35.6, 53.3, and 80.0 mg·kg;·day;) were intraperitoneally(i.p.) injected in rats for 3 weeks after BLM administration and DXM was used as the positive control(n=8 or 12). Arterial blood gas was assayed and morphological changes were observed. Lung mRNA expressions of tumor necrosis factor(TNF)-α, interleukin(IL)-1β, IL-6 and some cytokines in lung tissue were detected by real-time polymerase chain reaction. Nuclear factor-κB p65 or α-smooth muscle actin(α-SMA) protein distribution in rat lung tissue was observed by immunohistochemistry. Results: On the 7 th day after BLM administration, lung tissue showed serious inflammation. Treatment with HSYA or DXM ameliorated lung inflammation. After treatment with HSYA or DXM, oxygen partial pressure(PaO;) increased(HSYA 80.0 mg·kg;, P<0.01) and CO;partial pressure(PaCO;) decreased(HSYA 53.3, 80.0 mg·kg;, P<0.05). Moreover, the mRNA expression of TNF-α, IL-1β, and IL-6; and the number of NF-κB p65 positive cells was lower in HSYA 53.3 and 80.0 mg·kg;groups than those in the model group(all P<0.05). Twenty-one days after BLM administration, HSYA or DXM treatment ameliorated fibrosis, increased PaO;(HSYA 53.3, 80.0 mg·kg;, P<0.01), and decreased PaCO;(53.3 and 80.0 mg·kg;, P<0.05). Further, the mRNA expression of TGF-β1, α-SMA, and collagen Ⅰ as well as the number of α-SMA positive cells increased in the model group and HSYA can attenuate these changes(53.3, 80.0 mg·kg;, P<0.05). Hematoxylin and eosin and Masson’s trichrome staining indicated that the fibrosis and collagen deposition were ameliorated in HSYA groups(53.3, 80.0 mg·kg;, P<0.05). Conclusion: HSYA could alleviate acute lung inflammation and chronic pulmonary fibrosis induced by BLM in rats.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [21] Feitai attenuates bleomycin-induced pulmonary fibrosis in rats
    Gong, LK
    Li, XH
    Wang, H
    Zhang, L
    Cai, Y
    Qi, XM
    Liu, LL
    Liu, YZ
    Wu, XF
    Chen, FP
    Huang, CG
    Ren, J
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (05) : 634 - 640
  • [22] Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats
    Wang, HD
    Yamaya, M
    Okinaga, S
    Jia, YX
    Kamanaka, M
    Takahashi, H
    Guo, LY
    Ohrui, T
    Sasaki, H
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (03) : 406 - 411
  • [23] Protective Role of Andrographolide in Bleomycin-Induced Pulmonary Fibrosis in Mice
    Zhu, Tao
    Zhang, Wei
    Xiao, Min
    Chen, Hongying
    Jin, Hong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (12): : 23581 - 23596
  • [24] Effect of Antioxidant Echinochrome A on Bleomycin-Induced Pulmonary Fibrosis
    Lebed'ko, O. A.
    Ryzhavskii, B. Ya.
    Demidova, O. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 159 (03) : 351 - 354
  • [25] The effect of octreotide, an analog of somatostatin, on bleomycin-induced interstitial pulmonary fibrosis in rats
    Tug, Tuncer
    Kara, Haki
    Karaoglu, Aziz
    Karatas, Fikret
    Turgut, Nergiz Hacer
    Ayan, Erhan
    Boran, Cetin
    Tug, Esra
    DRUG AND CHEMICAL TOXICOLOGY, 2013, 36 (02) : 181 - 186
  • [26] The Protective Effects of Nebulized Nano-Curcumin Against Bleomycin-Induced Pulmonary Fibrosis in Rats
    Hemmati, Ali Asghar
    Karampour, Neda Sistani
    Dahanzadeh, Sedigheh
    Makhmalzadeh, Behzad Sharif
    Rezaie, Anahita
    Ghafourian, Mehri
    JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, 2021, 16 (02)
  • [27] Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats
    Gao, Lili
    Tang, Haiying
    He, Huanyu
    Liu, Jia
    Mao, Jingwei
    Ji, Hong
    Lin, Hongli
    Wu, Taihua
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [28] Role of thioredoxin nitration in bleomycin-induced pulmonary fibrosis in rats
    Wang, Lei
    Song, Yimin
    Li, Xiankui
    Guo, Haizhou
    Zhang, Guojun
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2016, 94 (01) : 59 - 64
  • [29] rhCygb benefits bleomycin-induced established pulmonary fibrosis in rats
    Li, Zhen
    Lin, Zhongshun
    Wang, Ping
    Dong, Wenqi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (07): : 2141 - 2152
  • [30] Efficacies of rosiglitazone and retinoin on bleomycin-induced pulmonary fibrosis in rats
    Yu, Wencheng
    Mi, Liyun
    Long, Teng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (01) : 609 - 615